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Abstract
Background & Aims: Liver is a target organ in many mitochondrial disorders, especially if the complex III assembly factor
BCS1L is mutated. To reveal disease mechanism due to such mutations, we have produced a transgenic mouse model with
c.232A.G mutation in Bcs1l, the causative mutation for GRACILE syndrome. The homozygous mice develop mitochondrial
hepatopathy with steatosis and fibrosis after weaning. Our aim was to assess cellular mechanisms for disease onset and
progression using metabolomics.
Methods: With mass spectrometry we analyzed metabolite patterns in liver samples obtained from homozygotes and
littermate controls of three ages. As oxidative stress might be a mechanism for mitochondrial hepatopathy, we also
assessed H2O2 production and expression of antioxidants.
Results: Homozygotes had a similar metabolic profile at 14 days of age as controls, with the exception of slightly decreased
AMP. At 24 days, when hepatocytes display first histopathological signs, increases in succinate, fumarate and AMP were
found associated with impaired glucose turnover and beta-oxidation. At end stage disease after 30 days, these changes
were pronounced with decreased carbohydrates, high levels of acylcarnitines and amino acids, and elevated biogenic
amines, especially putrescine. Signs of oxidative stress were present in end-stage disease.
Conclusions: The findings suggest an early Krebs cycle defect with increases of its intermediates, which might play a role in
disease onset. During disease progression, carbohydrate and fatty acid metabolism deteriorate leading to a starvation-like
condition. The mouse model is valuable for further investigations on mechanisms in mitochondrial hepatopathy and for
interventions.
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Introduction
The cytochrome bc1 complex (complex III, CIII) is composed
of one mitochondrial and ten nuclear encoded proteins that are
assembled with the help of two chaperones, BCS1L and TTC19.
The recently identified protein TTC19 aids assembly of early
subunits of CIII [1], whereas BCS1L finalizes it by inserting the
Rieske iron-sulfur protein (RISP) and QCR10P into the pre-
complex [2,3,4]. CIII deficiencies have been reported originating
from mutations in the mitochondrial encoded cytochrome b, the
nuclear encoded subunit VII, BCS1L and TTC19 [5,6]. More
than 20 pathogenic human BCS1L mutations have been causative
for CIII assembly defects that result in a broad spectrum of
symptoms ranging from congenital deafness [7], and myopathy
[8], to neonatal encephalopathy [1,9] or liver disorder usually with
proximal tubulopathy [10,11]. The most severe phenotype, the
autosomal recessive GRACILE syndrome (MIM 603358) is caused
by a missense mutation (c.232A.G) substituting serine for glycine
(p.S78G) in the N-terminus of the protein. The syndrome presents
with fetal growth restriction, aminoaciduria, cholestasis, iron
accumulation in the liver, and lactacidosis, and results in early
death within days or weeks [11,12].
To elucidate functions of BCS1L in general, and the
pathophysiologic mechanisms in GRACILE syndrome in partic-
ular, we introduced the Bcs1l c.232A.G mutation into mice [13].
The main findings in the homozygous (Bcs1lG/G) mice mimick the
human disorder and consist of growth failure from the fourth week
of live, progressive liver disorder with glycogen depletion and
microvesicular steatosis, proximal tubulopathy, and death before 6
weeks [13]. In mitochondria of all tissues, decreased BCS1L
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protein amount is associated with a deficient assembly of RISP
into CIII, resulting in a decreased CIII activity. As in GRACILE
patients, liver is the main affected organ and deteriorates quickly
in Bcs1lG/G mice.
The pathophysiologic mechanisms underlying the different
BCS1L disorders are unclear. However, in neonatal diseases
hepatopathy is a common finding. In this study, our aim was to use
the transgenic Bcs1lG/G mice to assess changes in liver function at
disease onset as well as at the end stage. Targeted metabolite
profiles in homogenized liver tissues from the animals was
performed in order to get a comprehensive picture of the effect
of the homozygous Bcs1l c.232A.G mutation on liver metabo-
lism. Compromised respiratory chain function may impair beta-
oxidation resulting in fatty acid accumulation and steatosis [14]
that further hamper the redox state of the respiratory chain
thereby causing oxidative stress [15]. We hypothesized that
oxidative stress might contribute to the rapid deterioration in the
liver of Bcs1lG/G mice and therefore assessed proposed [7,16,17]
effects of reactive oxygen species (ROS) as well as antioxidant
capacity of liver tissue.
Results
Effect of Genotype and Age on Metabolite Profiles
Comparing the pool of 198 detected metabolites to control
animals, significant differences at FDR,0.1 were found both due
to the mutation as such (102 compounds) and to the age of the
animal (177 compounds). Using the same threshold, 141
metabolites exhibited positive interaction between the presence
of the mutation and the age. A summary of the metabolites other
than glycerophosphatidylcholines and sphingomyelins is given in a
form of a heatmap in Fig. 1A (the latter groups are presented in
Fig. S1). Explicit fold changes of the metabolites for which the
impact of the mutation is age dependent (i.e. positive interaction at
FDR,0.1) are presented separately (Fig. 1B, 2A, 3A). Amongst
the 141 selected compounds, only one metabolite on day 14 (PC
aa C42:1, FC (log2) =20.39, q,0.007) and 20 metabolites on day
24 (14 phosphatidylcholines, 5 acylcarnitines and aspartic acid,
FC(log2) =20.24 to 0.74, q,0.05) were significantly different (Fig.
S1, Fig. 2A and 3A).
In an analysis of changes in sets of metabolites [18] glyceropho-
sphatidylcholines (n = 91 metabolites) and compounds of energy
metabolism (n= 9) were up-regulated on day 24 (p,0.05) whereas
sphingomyelins (n = 14) and acylcarnitines (n = 41) were not
significantly different (p,0.1 and p,0.2, respectively). No positive
association could be found on day 14 or for any other metabolite
class on day 24.
The most marked findings were increased metabolite levels in
liver tissue of the animals at the end stage of the disease, aged over
30 days; up to 4-fold changes for most amino acids (q,0.05 for 15
out of 21, Fig. 3A) and all detected bile acids (q,0.001, Fig. 1A,
Fig. S1). However, several short/medium length acylcarnitines
(Fig. 2A), components of the energy metabolism pathway (Fig. 1B),
and lipids (Fig. S1) were decreased. At 24 days of age, when initial
histopathological changes, ie glycogen depletion, appear (Fig. 1C),
levels of succinate, fumarate (Fig. 1B), acylcarnitines (Fig. 2A), and
aminoacids (Fig. 3A) were up-regulated compared to control
animals.
Impaired Energy Metabolism in Bcs1lG/G Mice
The initial change in carbohydrate metabolism in homozygotes
aged 24 days was an increase in succinate (Fig. 1B) concomitant
with the glycogen depletion seen in histological sections (Fig. 1C).
In these animals, also increases in medium- and long-chain
acylcarnitines were found (Fig. 2A). In sick animals, a 2- to 3-fold
increase was found in most medium- and long-chain acylcarni-
tines, whereas most short-chain acylcarnitines were decreased
(Fig. 2A) concomitant with a clear steatosis in liver histology
(Fig. 2B). Hexoses and lactic acid were decreased, whereas
adenosine monophosphate (AMP) and several glycogenic amino
acids were increased. Bile acids were highly increased in sick
animals (Fig. 1A).
Disturbance of Amino Acid Balance
Clearly increased amino acids were found in sick animals aged
over 30 days, with less prominent findings present already at 24
days in homozygotes (Fig. 3). None of the biogenic amines were
increased at 24 days, but clear increases were present in sick
animals, especially the 5-fold increase of putrescine (Fig. 3).
Oxidative Stress and Signs of Inflammation only in End
Stage Disease
In isolated mitochondria from sick Bcs1lG/G mice, lack of RISP
in CIII (Fig. 4A) was accompanied with functional deficit in
respiratory chain (Fig. 4B), but no differences in H2O2 production
compared to littermate controls (n = 3 pairs Fig. 4C). Neither was
any ROS effect found on mitochondrial proteins, ie the amount of
carbonylated protein was similar in Bcs1lG/G mice aged over 30
days and littermate controls (n = 7 pairs, Bcs1lG/G/Bcs1lA/A
relative value, mean 6 SD: 1.0960.36).
In liver tissue, significant increases for methionine-sulfoxide and
all detected prostaglandins (6 out of 15 that were screened for)
were found in sick animals aged over 30 days (Fig. 4D). The
antioxidant capacity of liver tissue, assessed on the basis of mRNA
levels, revealed no differences in the expression of any of the
antioxidant enzymes between homozygotes and controls aged 14
days (Fig. 4E). However, in end stage disease, expression of the
mitochondrial antioxidant genes manganese superoxide dismutase
and catalase was down-regulated, whereas the extracellular
glutathione peroxidase 3 was up-regulated (Fig. 4E).
Discussion
Since structural and functional CIII deficiencies develop
progressively in the organs of Bcs1lG/G mice, with the liver being
most affected [13] we investigated liver metabolites at three
different ages; before any tissue changes, at disease onset, and
when mice are clearly affected by the disease. The earliest
metabolite change was a slightly decreased level of AMP, followed
by increased levels of intermediates of the Krebs cycle concomitant
with an alteration of acylcarnitine metabolism and increases in the
amino acids alanine, glutamate, and aspartate, and in fatty acids.
These metabolomic changes were accompanied by the first signs
of tissue pathology as shown by glycogen depletion in livers from
Bcs1lG/G mice.
In the end stage of the disease, the spectrum of metabolite
changes was clearly different, demonstrating a liver deterioration
with severe energy deficit, cellular degeneration, oxidative stress,
and a starvation-like phenotype. The concomitant up-regulation of
larger acylcarnitines, AMP, and a majority of the lipids suggest a
decrease of the Krebs cycle activity, and a subsequent failure in
anticipated switch in hepatocytes towards beta-oxidation in
response to glycogen depletion. Decreased short-chain acylcarni-
tines indicate a limitation in beta-oxidation. A major deterioration
in liver function is reflected in the increase of most amino acids
and all detected bile acids.
Under normal conditions, the liver ensures normoglycemia by
glycogenolysis followed by increased gluconeogenesis [19]. During
Liver Metabolome of Complex III Deficient Mice
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starvation, fatty acids are mobilized from adipose tissue, proteins
are degraded and amino acids transported to the liver to serve as
substrates for gluconeogenesis. Increased beta-oxidation and
gluconeogenesis require energy forcing the respiratory chain to
produce more adenosine triphosphate (ATP) [20]. This metabolic
adaptation is compromised as CIII activity declines over time in
Bcs1lG/G mice [13]. The observed glycogen depletion, transient
increases in succinate and fumarate, persistent increases in
medium- and long-chain acylcarnitines, and transient decrease,
followed by accumulation of AMP are all consistent with this
sequence of events (Fig. 5).
Low lactate content in the liver, despite increased blood levels
[13], suggests that hepatocytes use it in gluconeogenesis. Main-
taining glucose homeostasis is dependent on glycogenolysis and
gluconeogenesis, which take place in liver and proximal tubules of
the kidney. This mechanism seems to fail in sick Bcs1lG/G mice, in
which liver and proximal tubules are the first and most affected
organs with progressive CIII deficiency [13]. Thus, an explanation
to liver being the most sensitive organ to CIII deficiency appears to
be a failure of the respiratory chain in hepatocytes to respond to
increased metabolic demands. In another mouse model with
tissue-specific deletions of the transcription factor Tfam, respiratory
chain deficiency seems to be successfully compensated by a switch
from fatty acid oxidation to glycolysis, and by increased
mitochondrial biogenesis, in myocardium [21] and in skeletal
muscle [21,22].
Energy starvation as well as respiratory chain deficiency may
result in liver fat accumulation [23]. Liver fatty acid metabolism
studies in mice under starvation demonstrated accumulation of
triacylglycerol with similar changes in lysophosphatidylcholine and
phosphatidylcholine profiles [24] as we identified in Bcs1lG/G
mice. Phosphatidylcholines are essential for CIII activity since
delipidation abolishes its function [25] indicating that enzyme-
bound phospholipids play an important role for activity of
respiratory chain complexes. The impact of respiratory chain
failure on steatosis was investigated in preadipocytes incubated
with the CIII inhibitor antimycin A. In these cells, accumulation of
triglyceride vesicles concomitant with an elevated glucose uptake
was present [26]. Likewise in sick Bcs1lG/G mice, microvesicular
steatosis increases with decreasing CIII activity [13].
A recent study in tumour cells with a mitochondrial DNA
mutation leading to lack of CIII activity showed that a glutamine-
dependent reductive carboxylation, needing isocitrate dehydroge-
nase 1 and 2, can compensate for impaired mitochondrial
oxidative metabolism [27]. Interestingly, acetyl CoA was mainly
formed through this pathway and thus glutamine was the major
precursor for synthesis of fatty acid. Increased intermediates were
succinate and fumarate [27]. At disease onset we found increased
Figure 1. Carbohydrate metabolism. (A) Heatmap depicting the log basis 2 fold changes in metabolite (rows) concentration determined in liver
tissues between matched pairs (columns) of homozygous (G/G, Bcs1lG/G) and littermate control (A/A, Bcs1lA/A) mice. Columns (i.e. matched pairs) are
reordered by hierarchical clustering (HCA, Ward aggregation method) using the age group (14, 24 and more than 30 days, .30) to label the tree
leaves. Metabolites are grouped according to chemical classification. (B) Explicit fold changes with their corresponding 95% confidence intervals for
all the carbohydrate intermediates measured in the three age groups. Significance levels: +, q,0.2; **, q,0.01 and ***, q,0.001. DHAP+3-PGA:
mixture of dihydroxyacetonephosphate and 3-phosphoglyceraldehyde. (C) Periodic acid-Schiff staining of liver sections showing progressive
glycogen depletion from 24 to 34 days old homozygotes.
doi:10.1371/journal.pone.0041156.g001
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levels of succinate and fumarate suggesting that such compensa-
tory reductive carboxylation might occur, in addition to a possible
signalling function of the intermediates [28] in Bcs1lG/G mice.
Liver samples at end stage disease in Bcs1lG/G mice contained
elevated levels of the biogenic amino acids spermidine and
putrescine, reflecting at least in part a limited capacity of the urea
cycle. Both spermidine and putrescine play important roles in
mediating cell death. Spermidine induces acetylation and
deacetylation of nuclear and cytoplasmic proteins resulting in
autophagy, removal of damaged cells and protein aggregates [29].
Biogenic amines are probably important for liver regeneration
judging from a metabolomics study showing highly elevated tissue
levels of putrescine and elevated levels of spermidine after partial
hepatectomy [30].
Impaired respiratory chain function due to CIII deficiency may
cause increased ROS production that together with liver steatosis
contribute to tissue deterioration [14]. Increased ROS production
has been found both in patient fibroblasts harbouring different
BCS1L mutations [7,17] and in mouse lung fibroblasts lacking
RISP [16]. In contradiction, RISP inactivation by siRNA in
hepatocyte and adipocyte cell cultures resulted in decreased levels
of H2O2 [31,32,33].
In livers of Bcs1lG/G mice, ROS modified metabolites such as
methionine sulfoxide and prostaglandins were detectable only at
end stage disease. Further, antioxidant defence was similar in
younger animals and changed only slightly in end stage disease
compared to controls. In contrast to findings in fibroblasts
harbouring other CIII deficiencies [7,16,17] no elevated H2O2
levels could be detected in liver mitochondria from Bcs1lG/G mice.
Controversy prevails concerning mitochondrial ROS production.
Generation of mitochondrial ROS varies depending on tissue and
substrate characteristics [34]. There are in vitro studies of CIV and
mtDNA deficiencies showing elevated ROS levels, whereas in vivo
models do not confirm oxidative stress in tissue [35,36,37].
Oxidative stress is believed to be a contributing factor for
disease phenotypes in disturbances of oxidative phosphorylation,
including in development of steatosis. Cytosolic accumulation of
fatty acids activates peroxisomal beta-oxidation and microsomal
omega-oxidation resulting in ROS production [20]. Contradictory
to our hypothesis, we did not find signs of increased oxidative
stress at early time points. Only in the end stage disease, ROS
modified metabolites such as methionine sulfoxide and prosta-
glandins were slightly increased in the metabolomics analysis,
suggesting no major role of ROS in the onset of the disease.
Hepatocyte energy production is regulated by the energy
sensors AMP kinase (AMPK) and members of the sirtuin family of
NAD+ dependent deacetylases [38]. Decreased oxidative phos-
phorylation results in increased AMP/ATP and NAD+/NADH
ratios thereby switching on catabolic pathways. AMPK activation
in mitochondrial deficiencies is important for regulation of
increased mitochondrial biogenesis. This was shown experimen-
tally using an AMP precursor, AICAR, to correct complex IV
deficiency in mouse muscle [39]. Furthermore, mice lacking the
mitochondrial expressed Sirtuin 3 show signs of disturbed beta-
oxidation under starvation such as accumulation of intermediates
of fatty acid oxidation. In these mice, long-chain acyl CoA
dehydrogenase was hyperacetylated resulting in reduced enzymat-
ic activity and accumulation of long-chain acyl carnitines [40].
Long-chain acyl carnitines were accumulated in the sick Bcs1lG/G
mice suggesting a possible disturbance in Sirtuin 3 activation.
In conclusion, using metabolomics we have shown that
respiratory chain dysfunction in Bcs1lG/G mice due to CIII
deficiency leads to a starvation-like condition with energy
depletion. The findings suggest that the initial disturbances are
decreased glycolysis and beta- oxidation concomitant with a
decreased ATP production. Impaired mitochondrial metabolism
cannot be corrected by eg. the proposed compensatory reductive
carboxylation [27] and thus a circulus vitiosus occurs with exhausted
energy supply and failing compensatory mitochondrial biogenesis
to energy deprivation. Oxidative stress is not a central regulatory
mechanism for disease onset, but may appear at the end stage of
the disease. We envision that our mouse model can be used for
further investigations on disease mechanisms in respiratory chain
failure and for exploring interventions.
Materials and Methods
Mice
All animal experiments were performed with the approval of the
Lund regional animal research ethic committee, Sweden (permits
M170-06, M158-08, 31-8265/08). The Bcs1l c.232A.G mutation
was introduced into mice using gene targeting [13]. Mice of mixed
genetic background were maintained on rodent diet (Labfor R34,
Lactamin, Stockholm, Sweden) and water was available ad libitum
Figure 2. Acylcarnitines and lipid accumulation. (A) Log2 fold changes of the acylcarnitines found significant at a false discovery rate ,0.1 in
the three age groups (14, 24 and .30 days) between matched pairs of homozygous (G/G, Bcs1lG/G) and control (A/A, Bcs1lA/A) mice. Metabolites are
presented in the increasing order of their molecular weight. Significance levels are defined as: +, q,0.2; *, q,0.05; **, q,0.01 and ***, q,0.001. (B)
Oil-Red-O staining showing microvesicular lipid accumulation in hepatocytes of sick animal (34d), only.
doi:10.1371/journal.pone.0041156.g002
Figure 3. Amino acids and biogenic amines. (A) Log2 fold changes
of amino acids and biogenic amines found significant at false discovery
rate ,0.1 in the three age groups (14, 24 and .30 days) between
matched pairs of homozygous and control mice. Sick homozygotes
(indicated as .30 days) have significantly elevated levels of the two
metabolite groups, especially the cell signalling amine putrescine.
doi:10.1371/journal.pone.0041156.g003
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in a vivarium with 12 h light/dark cycle at 22uC. Bcs1lG/G mice of
three age groups were studied; on postnatal day 14, when the
animals are healthy (n = 14, nine males) and on day 24 (n= 8, all
males), when initial histopathological findings appear, and on day
30 or more (median 34 days, range 30–43, n = 18, eleven males),
when the animals are sick. The same numbers of littermate wild
type mice (Bcs1lA/A) or heterozygotes (Bcs1lA/G) at each age were
used as controls. Animals were sacrificed by cervical dislocation.
Liver tissue samples were either immediately frozen on dry ice,
fixed in 4% buffered formalin or used for the isolation of
mitochondria [13]. The formalin-fixed tissues were embedded in
paraffin according to normal pathology laboratory routine; slices
were stained with hematoxylin-eosin for basic morphology and
with periodic acid–Schiff with and without diastase for glycogen
detection. From snap-frozen liver tissues standard Oil-Red-O fat
staining was performed.
Metabolomic Analysis
Frozen liver samples were weighed into 2 ml Precellys tubes
(Peqlab Biotechnologie GmbH, Erlangen, Germany) equipped
Figure 4. Respirometry and H2O2 production in mitochondria with RISP depleted CIII (A-C), and signs of oxidative stress in liver
tissue (D, E). (A) Blue Native PAGE and Western blot showing decreased Rieske iron sulphur protein (RISP) incorporation in CIII in mitochondria from
two representative Bcs1lG/G (G/G1, G/G2) mice compared to wild type (A/A1, A/A2) aged .30 d. (B) Respiratory chain oxygen consumption under
convergent substrate input in CI and CII is impaired in G/G1. (C) Similar H2O2 production was detected with Amplex Red in isolated mitochondria of
G/G1 and A/A1 mice. (D) In liver tissue homogenates of three age group animals, metabolomic analyses showed that log2 fold changes of the
oxidative stress markers were significantly increased in sick animals only (.30 days). (E) Antioxidant defence in liver tissue measured with quantitative
PCR in 14 days old and sick (.30 d) homozygotes expressed as relation to b-actin. In sick animals manganese superoxide dismutase (MnSOD) and
catalase (Cat) were decreased, whereas glutathione peroxidase 3 (GPx-3) was increased.
doi:10.1371/journal.pone.0041156.g004
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with ceramic beads. Tissues were homogenized using ethanol/
dichloromethane (1/1) as extraction solvents [41]. Homogenates
were centrifuged at 18000 g at 2uC for 5 min, the resulting
supernatants were pipetted into a cryovial (1.5 ml, Biozym GmbH,
Figure 5. Hypothetic diagram of metabolic changes in hepatocytes in relation to disease progression in Bcs1lG/G mice. (A) With
decreasing incorporation of Rieske iron sulphur protein (RISP) in complex CIII (CIII), the activity decreases and symptoms appear; at less than 50%
incorporation growth failure starts. (B) Metabolomic changes in association with decreased CIII activity and respiratory chain dysfunction are depicted
in red. Initial metabolic changes are elevated levels of succinate, aspartate and glutamate. Glycogen depletion leads to lack of glucose and lactate and
induces beta-oxidation and protein breakdown resulting in accumulation of fatty acids and acylcarnitines as well as of the biogenic amines
putrescine and spermidine. PDH. Pyruvate dehydrogenase complex, CPT1/2: Carnitine palmitoyl transferases 1 and 2. GAP, glyceraldehyde- 3
phosphate, DHAP, Dihydroxy acetone phosphate.
doi:10.1371/journal.pone.0041156.g005
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Oldendorf, Germany) and analyzed immediately to avoid
degradation of the analytes.
Flow injection analysis (FIA-MS/MS) based platform was
employed for the simultaneous quantification of a broad range
of endogenous intermediates, namely acylcarnitines, amino acids,
sphingomyelins and glycerophospholipids. A chromatographic
step (LC-MS/MS) was applied for the additional quantification
of a series of amino acids and biogenic amines, small organic acids
and other components from the energy metabolism pathway, bile
acids, and eicosanoids. Samples were randomized on the plate
prior to analysis to avoid potential confounding interaction
between concentration and order of injection. Detailed experi-
mental protocols have been published previously [41,42]. FIA-
MS/MS data were quantified with MetIQ software (integral part
of AbsoluteIDQ kit p150, BIOCRATES Life Sciences AG,
Innsbruck, Austria) and LC-MS/MS data were quantified with
Analyst 1.4.2 software (Applied Biosystems, Darmstadt, Germany).
All methods are validated for human plasma considering FDA
Guidance for industry – Bioanalytical Method Validation. The
initial pool of 253 measurements [42] was reduced to 198 by
excluding 21 redundant analytes as well as 34 analytes for which
detection rates were lower than 80%. In short, the final panel
entering data analyses and interpretation consists of 41 acylcarni-
tines, 9 components of the energy metabolism, 21 amino acids, 11
biogenic amines, 6 bile acids, 6 prostaglandins, 91 glyceropho-
sphatidylcholines, and 13 sphingomyelins. A comprehensive list of
all metabolites that underwent further statistical treatment is
provided in Table S1 alongside the adopted nomenclature for
annotating metabolites.
Statistical Analysis of Metabolomic Results
Measurement data were imported to the environment R (R
Development Core Team, 2011, R: A language and environment
for statistical computing. R Foundation for Statistical Computing,
Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-
project.org/.) for data sorting, statistical analyses and data
presentation. All calculations were performed on the log basis 2
transformed concentration data with the non-detect imputed as
previously published [43]. Adhering strictly to the initial
experimental design, age and genotype effects and their interaction
were estimated by general least squares regression. P values were
obtained from likelihood ratio tests. Fold changes in log basis 2
were directly extracted from the linear model and presented with
their 95% confidence intervals. To account for the large number
of inferences being made, metabolites were initially selected on the
basis of the false discovery rate (FDR) [44] and denoted as the
FDR in the text. Adjustment [45] was adopted at individual
metabolite level to control the family-wise error rate (denoted as q
value, in the text). For testing whether set of metabolites, rather
than individual compounds, were up-regulated at day 14 and 24
we applied a recently developed method [18] to each chemical
class.
Analysis of Respiratory Chain Assembly by Blue Native
PAGE
Mouse liver mitochondria were isolated and processed for Blue
Native PAGE and Western blot as described previously [13].
Respiratory chain complexes were identified with antibodies
(MitoSciences, Eugene, Oregon, USA) detecting respiratory chain
subunits CIII/RISP, CIV/COX and CII/30 kDa subunit,
respectively.
Analysis of Respiratory Chain Activity with High
Resolution Respirometry
Respiratory chain function was analysed in isolated mitochon-
dria incubated in MIR 05 (110 mM sucrose, 20 mM HEPES,
20 mM Taurine, 60 mM K- lactobionate, 3 mM MgCl2,
10 mM KH2PO4, pH 7,1) by high resolution respirometry using
the substrate- uncoupler- inhibitor protocol [46] as described
previously [13].
Assessment of Hydrogen Peroxide by Amplex Red
Isolated mitochondria were incubated at 37uC in assay medium
(MIR 05) supplemented with 4 ml horseradish peroxidase,
superoxide dismutase and Amplex red according to the instruc-
tions of the manufacturer (Invitrogen, Carlsbad, CA, USA). Under
these conditions, increased fluorescence indicates H2O2 release
from mitochondria or superoxide released from mitochondria and
converted to H2O2 by addition of superoxide dismutase.
Fluorescence was measured after addition of substrate and
inhibitors for the respiratory chain complexes in a Perkin Elmer
fluorometer and analyzed with FL Winlab software. Increased
fluorescence/time (relative units) is direct proportional to in-
creased H2O2 release after subsequent substrate and inhibitor
addition.
Carbonylated Proteins
Protein oxidation by ROS was measured as carbonyl group
production. Isolated mitochondria were incubated with DNP-
hydrazine for 45 min at room temperature. The mixture was
diluted with PBS, and 100 ml were used to coat a 96 well plate that
was incubated over night at 4uC. The wells were washed three
times with 0.9% NaCl+0.05% Tween-20. Then the plate was
incubated with primary antibody, anti DNP (Invitrogen, Carlsbad,
CA, USA), diluted 2000 times in incubation buffer (PBS, 0.1%
BSA, 0.25% Tween 20) for 1 h incubation at 37uC, washed and
incubated with secondary antibody, Swine-Anti-rabbit IgG-HRP,
(Dako A/S; diluted 2000 times in incubation buffer) for 1 h at
room temperature. At the end the plate was incubated with
substrate solution (O-phenylenediamine, Dako S2045) according
to the recommendations of the manufacturer. The extinction at
490 nm was measured on a spectrophotometer (1420 Multilabel
counter VICTOR3, Perkin Elmer) [47,48].
RNA Preparation and Quantitative PCR to Assess
Antioxidant Defense
Frozen liver tissue samples were placed in lysis buffer included
in the RNeasy kit and homogenized in a TissueLyser (Qiagen,
Hilden, Germany). RNA was extracted from the lysate using the
RNeasy kit from Qiagen according to the instructions of the
manufacturer and RNA quality was analyzed by agarose gel
electrophoresis.
For cDNA synthesis 500 ng total RNA were reverse transcribed
using the TaqmanH reverse transcription reagents from Applied
Biosystems and random hexamer primers included in the kit. The
resulting cDNA was used as template in quantitative PCR on an
Applied Biosystems StepOne cycler using Taqman Gene Expres-
sion assays from Applied Biosystems for the specific genes. The
variation in replicates is shown as mean 6SD.
Supporting Information
Figure S1 Lipid metabolism. Heatmap depicting the log
basis 2 fold changes in lipid (rows) concentration determined in
liver tissues between matched pairs (columns) of homozygote (G/
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PLoS ONE | www.plosone.org 8 July 2012 | Volume 7 | Issue 7 | e41156
G, Bcs1lG/G) and control (A/A, Bcs1lA/A) mice. Columns (i.e.
matched pairs) are reordered by hierarchical clustering (HCA,
Ward aggregation method) using the age group (14, 24 and 30+
days) to label the tree leaves. Metabolites are grouped according to
the chemical classification employed in the manuscript. To
facilitate the reading, fold changes are truncated at +/2 2 and
light grey lines are drawn around the main groups highlighted by
HCA and chemical classes.
(TIF)
Table S1 Metabolite panel. List of metabolites used in this
study.
(DOC)
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